HTS 2939 · Japan · duty record
Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives
Product description (continued): Goods in HTS heading 2939 from Japan pay the general duty in the tariff schedule, and the rules in our table add nothing on top. Across the 24 lines below the percentage total runs from 0% to 6.5%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.
Selected line / duty components
General schedule rate: Free
Alkaloids of opium and their derivatives; salts thereof › Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof
Click any code in the table below to show that line here.
Duty by line
24 tariff lines · JapanPick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.
24 lines shown
| Code | Product | General rate | Added duties | Total percentage | On $10,000 |
|---|---|---|---|---|---|
| Alkaloids of opium and their derivatives; salts thereof › Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof | Free | none in our table | 0% | $0.00 | |
| Other › Papaverine and its salts | Free | none in our table | 0% | $0.00 | |
| Other › Synthetic | Free | none in our table | 0% | $0.00 | |
| Other › Other | Free | none in our table | 0% | $0.00 | |
| Alkaloids of cinchona and their derivatives; salts thereof › Quinine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids of cinchona and their derivatives; salts thereof › Other | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Caffeine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Ephedrine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Pseudoephedrine (INN) and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Cathine (INN) and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Norephedrine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Levometamfetamine, metamfetamine (INN), metamfetamine racemate and their salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Other | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Fenetylline (INN) and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Other | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Ergometrine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Ergotamine and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Lysergic acid and its salts | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Other | Free | none in our table | 0% | $0.00 | |
| Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives › Cocaine, ecgonine; salts, esters and other derivatives thereof | Free | none in our table | 0% | $0.00 | |
| Other › Atropine (INN) and its salts | Free | none in our table | 0% | $0.00 | |
| Other › Other | Free | none in our table | 0% | $0.00 | |
| Other › Saxitoxin | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Other | 6.5% | none in our table | 6.5% | $650.00 |
What is and is not counted
Section 232: what the proclamations say about chapter 29
These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.
Pharmaceuticals and pharmaceutical ingredients in force
- Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
- Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.
Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)
Pending and recent notices for this heading
None of the notices we track names heading 2939 and Japan together. Many notices name only a program or a chapter, so also read all pending notices.